Therapeutic Management of Transmissible Venereal Tumour in Dogs
DOI:
https://doi.org/10.48165/ijvsbt.19.4.16Keywords:
Dog, FNAC, Histology, Impression smear, Therapeutic management, Transmissible venereal tumourAbstract
A total of 18 dogs affected with transmissible venereal tumour (TVT) were studied for therapeutic management under three groups each of 6 animals using vincristine alone (group 1), bacillus Calmette-Guerin alone (BCG) (group 2), and a combination of BCG and vincristine (group 3). Dogs having TVT were subjected to the confirmatory diagnosis using fine needle aspiration cytology (FNAC), impression smear and histopathological examinations prior to treatment. Treated dogs were monitored for their response to therapy with regards to physical regression of tumour masses along with histological changes. Complete regression of tumour masses was observed in the dogs treated with vincristine alone and combination of BCG and vincristine therapies. No such regression of tumour masses was observed in the dogs treated with BCG alone. Histologically the response of the tumour mass to the treatment was evinced by the appearance of macrophages and increased numbers of tumour infiltrating lymphocytes (TILs) followed by tumour cell apoptosis and necrosis with reduction in the mitotic index in group 1 and 3. The study indicated that combined therapy comprising BCG and vincristine was more effective than vincristine alone in treating TVT, however, BCG alone was not effective.
Downloads
References
Böhle, A., & Bock, P.R. (2004). Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: Formal meta-analysis of comparative studies on tumor progression. Urology, 63(4), 682-686.
Byrne, M.J., & Reynoldst, P.M. (1982). Phase II study of cyclophosphamide, vincristine and DTIC+BCG in the treatment of malignant melanoma. Australian and New Zealand Journal of Medicine, 12(4), 263-266.
Das, U., Das, A.K., Das, D., & Das, B.B. (1991). Clinical report on the efficacy of chemotherapy in canine transmissible venereal sarcoma. Indian Veterinary Journal, 68(3), 249-252.
Han, R.F., & Pan, J.G. (2006). Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer. A meta-analysis of randomized trials. Urology, 67(6), 1216-1223
Hess, K.R., Anderson, K., Symmans, W.F., Valero, V., Ibrahim, N., Mejia, J.A., & Pusztai, L. (2006). Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. Journal of Clinical Oncology, 24(26), 4236-4244.
Hiblu, M.A., Khabuli, N.M., & Gaja, A.O. (2019). Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya. Open Veterinary Journal, 9(2), 103-105.
Knottenbelt, D.C., & Kelly, D.F. (2000). The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Veterinary Ophthalmology, 3(2-3), 169-191.
Krithiga, K., Manohar, B.M., & Balachandran, C. (2005). Cytological and histopathological study on cutaneous round cell tumours in canines. Indian Journal of Veterinary Pathology, 29, 38-41.
Morales, A., Chin, J.L., & Ramsey, E.W. (2001). Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder. Journal of Urology, 166, 1633-1638.
Mukaratirwa, S., Chitanga, S., Chimatira, T., Makuleke, C., Sayi, S.T., & Bhebhe, E. (2009). Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: Therapeutic efficacy and histological changes. Journal of the South African Veterinary Association, 80(2), 92-96.
Patard, J.J., Saint, F., Velotti, F., Abbou, C.C., & Chopin, D.K. (1998). Immune response following intravesical Bacillus Calmette-Guerin instillations in superficial bladder cancer: A review. Urological Research, 26(3), 155-159.
Pryor, K., Stricker, P., Russell, P., Golovsky, D., & Penny, R. (1995). Antiproliferative effects of bacillus Calmette-Guérin and interferon α2b on human bladder cancer cells in vitro. Cancer Immunology, Immunotherapy, 41(5), 309-316.
Saibaba, M., Lakshmi, N.D., & Phaneendra, M.S. (2015). Successful chemotherapeutic management of TVT in dogs: A report of 24 cases. International Journal of Innovative Science, Engineering & Technology, 2(8), 370-374.
Said, R.A., Silva, L.F., Albuquerque, A.R.O.L., Sousa-Neta, E.M., & Lavinsky, M.O. (2009). Efficacy and side effects of vincristine sulphate treatment on canine transmissible venereal tumour world small animal veterinary association world congress proceedings, 2009. In Proceeding... São Paulo: Wsawa Congress.
Saravanan, M., Shafiuzama, M., & Ranjithkumar, M. (2015). Generalized cutaneous and genital form of transmissible venereal tumor (TVT) in a mongrel dog and its therapeutic management. International Journal of Current Research, 7, 11586-11589.
Sethawongsin, C., Tangkawattana, S., Rungsipipat, A., & Techangamsuwan, S. (2018). Computerized cytomorphometric and cytomorphological analysis of canine transmissible venereal tumours. Journal of Comparative Pathology, 163, 18-22.
Sylvester, R.J. (2002). Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. Journal of Urology, 168, 1964-1970.
Tella, M.A., Ajala, O.O., & Taiwo, V.O. (2004). Complete regression of transmissible venereal tumor (TVT) in Nigerian mongrel dogs with vincristine sulphate chemotherapy. African Journal of Biomedical Research, 7(3), 133-138.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
